Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Pregnancy-related thromboembolism in women with sickle cell disease: An analysis of National Medicaid Data.

  • Read more about Pregnancy-related thromboembolism in women with sickle cell disease: An analysis of National Medicaid Data.

Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study.

  • Read more about Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study.

Clinical Features Associated with Thrombotic Events in Children with Myeloproliferative Neoplasms.

  • Read more about Clinical Features Associated with Thrombotic Events in Children with Myeloproliferative Neoplasms.

Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemia.

  • Read more about Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemia.

Diagnostic work-up for severe aplastic anemia in children: Consensus of the North American Pediatric Aplastic Anemia Consortium.

  • Read more about Diagnostic work-up for severe aplastic anemia in children: Consensus of the North American Pediatric Aplastic Anemia Consortium.

Clinical outcomes after 4.5?years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results.

  • Read more about Clinical outcomes after 4.5?years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results.

Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial.

  • Read more about Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial.

Ischemic stroke in children and young adults with sickle cell disease in the post-STOP era.

  • Read more about Ischemic stroke in children and young adults with sickle cell disease in the post-STOP era.

Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.

  • Read more about Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.

Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.

  • Read more about Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.

Pagination

  • Page 1
  • Next page ››
Subscribe to American journal of hematology

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List